The World Anti-Doping Agency (WADA) has announced that it will appeal the decision to clear world No. 1 tennis player Jannik Sinner after he tested positive for a banned substance earlier this year. Sinner, who tested positive for Clostebol in March 2024, was initially found not at fault by an independent tribunal, which allowed him to avoid suspension. However, WADA is now pushing for a suspension of up to two years.
Background
In March 2024, Sinner provided two positive samples for Clostebol, an anabolic steroid, at the Indian Wells tournament. According to Sinner, the positive results were caused by inadvertent contamination from his physiotherapist, who had used an over-the-counter spray to treat a wound. The physiotherapist applied the spray without gloves, which allegedly led to the contamination due to skin lesions on Sinner’s body.
The International Tennis Integrity Agency (ITIA) accepted Sinner’s explanation after consulting with experts, ruling that he bore no fault in the situation. This decision lifted his provisional suspension, allowing him to continue competing.
WADA’s Appeal
Despite the ITIA’s ruling, WADA has stated that the decision was “not correct under the applicable rules” and is now seeking a suspension for the Italian tennis star. WADA is not looking to strip Sinner of any results except the disqualification already imposed at Indian Wells, where he reached the semifinals and lost his prize money and ranking points.
Sinner expressed disappointment with WADA’s appeal, stating that he was “surprised” by the decision after multiple hearings ruled in his favor. He remains focused on his tennis, recently securing a victory in the round of 16 at the China Open.
